Project Grant R25DA061823
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$300K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55414, USA
Similar Awards
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $257,522 Project Grant (R25DA061764) to the University of Mississippi to develop a multimodal and interdisciplinary data science training program. The program aims to enhance a diverse workforce for addiction research by providing specialized training in artificial intelligence (AI) and machine learning (ML) methods. Key program components include webinars, summer...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $305,627 Project Grant to the Marine Biological Laboratory (MBL) in Woods Hole, Massachusetts. The purpose of this 3-year grant is to support the "BRAINS MINDS AND MACHINE ADVANCED RESEARCH TRAINING COURSE" which aims to cultivate a community of leaders with a deep understanding of neuroscience, cognitive science, and computer science. The course will engage students...
The National Institute on Drug Abuse (NIDA) awarded a $818,513 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the Regents of the University of Minnesota to investigate the role of dopamine signaling in the basolateral amygdala in regulating individual differences in reward-based learning strategies and addiction-like behaviors. The 5-year grant, which commenced on Sep 15, 2024, will focus on examining how individual differences in Pavlovian reward learning approaches...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is intended to develop and offer an "Interdisciplinary Summer Institute on the Analysis of Complex, Large-Scale Longitudinal Data". The $623,300 award, with a performance period from September 15, 2024 to July 31, 2027, will be used to train 50 interdisciplinary participants annually, including students, postdocs, and faculty, on the innovative...
This $265,302 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to investigate the neural mechanisms underlying opioid use disorder (OUD) and relapse risk during abstinence. The funded project will map the functional and anatomical pathways between the anterior and posterior paraventricular nucleus of the thalamus (PVT) and the nucleus accumbens (NAc), which have been implicated in the...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $315,533 to support the ABCD-REPRONIM educational program. The program aims to train researchers in responsible and reproducible analyses of data from the Adolescent Brain Cognitive Development (ABCD) study. Key products and services include: A 16-week online course providing didactic training on topics such as statistical and socioenvironmental...
This Project Grant award from the National Institute on Drug Abuse (NIDA), with the official CFDA program title "Drug Use and Addiction Research Programs", is funding the development of an educational intervention to train a diverse workforce in addiction data science. The $136,320 award will support the creation of an immersive, tailored addiction data science skills course that provides hands-on training in areas such as FAIR data principles, computational analytics, and natural...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,134,928 to the Regents of the University of Minnesota to develop novel, brain-penetrant, small molecule biased allosteric modulators (BAMs) of the neurotensin receptor 1 (NTSR1) to attenuate relapse to opioid seeking in individuals with opioid use disorder (OUD). The research aims to validate NTSR1 as a drug target for OUD treatment and discover...
This $1,078,339 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the "PREPARING INDIGENOUS SCIENTISTS TO LEAD INNOVATIVE SUBSTANCE USE RESEARCH: THE NATIVE CHILDREN'S RESEARCH EXCHANGE SCHOLARS PROGRAM". The grant aims to foster the development of early career Indigenous substance use and disorder researchers, particularly those focused on the impacts and developmental course of problematic...
The National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 - Drug Use and Addiction Research Programs, awarded a $1,965,600 Project Grant to the Regents of the University of Colorado, doing business as the University of Colorado-Denver. The grant titled "Precision Pharmacogenomics and Indigenous Research: A Novel Approach to Tobacco Cessation Efficacy in American Indian Communities" aims to leverage genome-wide and epigenome-wide association studies to better understand the...